CN102742705A - 黄精三叶茶 - Google Patents
黄精三叶茶 Download PDFInfo
- Publication number
- CN102742705A CN102742705A CN2012102573988A CN201210257398A CN102742705A CN 102742705 A CN102742705 A CN 102742705A CN 2012102573988 A CN2012102573988 A CN 2012102573988A CN 201210257398 A CN201210257398 A CN 201210257398A CN 102742705 A CN102742705 A CN 102742705A
- Authority
- CN
- China
- Prior art keywords
- sealwort
- parts
- tea
- sanye
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 25
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 18
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 18
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims description 9
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 230000036541 health Effects 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 201000001421 hyperglycemia Diseases 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 3
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 206010042496 Sunburn Diseases 0.000 abstract description 2
- 210000005075 mammary gland Anatomy 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000009758 senescence Effects 0.000 abstract 2
- 206010067982 Butterfly rash Diseases 0.000 abstract 1
- 206010008570 Chloasma Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 239000000049 pigment Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 17
- 239000003814 drug Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000035922 thirst Effects 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- -1 carrotene Chemical class 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- IADUEWIQBXOCDZ-VKHMYHEASA-N Azetidine-2-carboxylic acid Natural products OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种黄精三叶茶,其是由以下重量配比的原料配制而成:黄精30—35份,桑叶30—36份,柿叶19—26份,荷叶14—21份。本发明含有多种活性物质和30余种微量元素。具有益气养阴、活血化瘀、润肤养颜、减肥降脂、乌须黑发、清除血内瘀毒,延缓机体衰老,对预防和治疗各类癌症均有一定疗效。对高血压、高血脂、高血糖、心脑血管病、月经不调、乳腺增生、更年期综合症、蝴蝶斑、老年斑、日晒斑、褐色斑、黑眼圈、眼带、白发等均有非常明显的效果。它是一种养颜、保健、延缓衰老的饮用佳品。
Description
技术领域
本发明属于中药养生茶领域,具体涉及一种黄精三叶茶。
背景技术
随着人们生活水平不断提高、饮食结构改变、环境污染和生活节奏加快等诸多因素,一些文明病、富贵病严重威胁着人类健康。中国快步进入老年社会,心脑血管病、高血压、高血脂、高血糖、肿瘤等如潮汹涌,防病治病成为我国政府民生工程的重大课题,往往人们倾向于病后服药,这样不但给病人带来身体上的痛苦,同时也给家庭造成很大的经济负担。目前,在我国大多中老年人,上班族和公务员都有饮茶习惯,但又担心多饮之后容易失眠,并且随之人们生活水平的不断提高,对饮用茶的要求已不局限于解渴,而那些具有保健功能的茶越来越受欢迎。
目前,市面上销售的各种各样的保健茶品种繁多,如绿茶、红茶、功夫茶等,它们只起到清热、解渴、提神的作用,且功能单一,效果不怎么理想,尤其对人的保健作用不大。随着人们生活水平的提高,对原有茶的质量和口味已经远远不能满足人们的需求,人们渴望有一种利用纯天然中药制成的一种既能保健养生,又能防病治病的中药养生茶。
发明内容
本发明所要解决的技术问题是提供一种黄精三叶茶,既有茶的口感,又能促进睡眠,调解血压、降血糖、降血脂、抗疲劳、润肤养颜、延缓衰老、增强免疫力等功效。
本发明的技术方案:一种黄精三叶茶,其是由以下重量配比的原料配制而成:黄精30—35份,桑叶30—36份,柿叶19—26份,荷叶14—21份。
本发明优选的技术方案:它是由以下重量配比的原料配制而成:黄精32.5份,桑叶33份,柿叶22.5份,荷叶17.5份。
本发明的制备方法:(1)采集原料:黄精:以春秋采收,以秋采者质佳,挖去根茎,除去地上部分及须根,洗去泥土,置蒸笼内蒸至呈现油润时,取出晒干或烘干,反复九次;桑叶:10--11月间采收,除去杂质,晒干;柿叶:取秋季自然脱落之柿叶,或霜降时采摘的柿叶;荷叶:6--9月采收,除去叶柄,晒之七八成干,对折成半圆形晒干,夏季也可用鲜叶或初生嫩叶;(2)将桑叶、柿叶、荷叶上蒸笼蒸3—5分钟,拿出晒干,放锅内先武火后文火,翻炒,翻炒要内外均匀,微焦微香,即可出锅。(3)将上述原料粉碎至120目,按上述比例配好包装。
药物功效:黄精:入肺、脾、肾三脏。补中益气,除风湿,安五脏,久服轻身,润心肺,强筋骨,益精髓,治白发。
《本草纲目》:“黄精受戊己之淳气,故为补皇宫之胜品,土者万物之母,母得其养,则水火既济,木金交合,而诸邪自去,百病不生矣。”神仙芝草经云:“黄精宽中益气,使五脏调良,肌肉充盛,骨髓坚强,其力增倍,多年不老,颜色鲜明,发白更黑,齿落更生”。圣惠方:“用黄精,一年内变老为少。”
现代医学研究:黄精含黏液质、淀粉和糖分以及吖丁啶-2-羧酸、天门冬氨酸、高丝氨酸、二氨基丁酸、毛地黄糖甙以及多种蒽醌类化合物.能提高肝脏中超氧化物歧化酶活性,增强机体健康水平,延缓衰老,提高人体免疫力,增强心脏收缩力,增加冠脉流量。抑制肝糖酵解系统降低血糖,可使主动脉壁内膜斑块溶解,减轻冠状动脉粥样硬化程度。临床多用于治疗和预防冠心病、高血脂、高血糖、高血压、慢性肝炎、白细胞减少、免疫功能低下等。
桑叶:入肺、肝经。能疏散风热、清肺润燥、平抑肝阳、清肝明目、凉血止血。
《本草纲目》:“桑叶除寒热、利五脏、通关节、下气、利大小肠、去老风及宿血、劳热咳嗽、明目长发”。
现代医学研究:桑叶富含黄酮忒、酚类、氨基酸、有机酸、胡萝卜素、维生素及多种人体必需的微量元素具有较强抗氧化功效。桑叶富含稀有元素有机硒、锗,可清除体内自由基,使蓄积在人体内的毒素和废物被氧化,增加血液中的含氧量,促进新陈代谢和微循环。 对于高血脂、高血糖、脂肪肝、冠心病、高血压以及癌症术后放化疗病人的康复有非常好的辅助作用。
近年来研究证明,桑叶具有良好的皮肤美容作用,能改善和调节皮肤组织的新陈代谢,对抑制色素沉着的发生和发展。
特别是对脸部的痤疮、褐色斑有明显的疗效。
柿叶:入心、肺、大肠经。能清热、润肺、止渴。
《日华子本草》:“柿叶润心肺、止渴、涩肠、疗肺痿、心热、咳嗽、消痰、开胃、治吐血”。《别录》:“解酒热毒、止口干、压胃间热”。
现代医学研究:柿叶含黄酮甙、鞣质、酚类、树脂、香豆精类化合物、还原糖、多糖、挥发油、有机酸(白桦酯酸、齐墩果酸、熊果酸)、叶绿素、胡萝卜素和丰富的维生素C。从柿叶中提出的黄酮甙能软化血管,增强血管弹性,降低血压并增加冠脉流量。对金黄色葡萄球菌、卡他球菌有一定的抑制作用。柿叶含维生素C是柠檬的20倍。并含有芦丁、胆碱、蛋白质、矿物质、糖等成份。长期饮用能稳定血压、降低血脂、防止动脉硬化和冠心病,柿叶能促进机体生成抗癌,抗流行病病毒的干扰素,对各种癌症、流感均有较好的作用。
荷叶:入心、肝、脾经。能清暑利湿,生发清阳,清热解毒。
《纲目》:“荷叶能生发阳气,散瘀血,留好血。此药易得而活人甚多。”又戴原礼《证治要诀》:“荷叶服之,令人瘦劣。单服可以消阳水浮肿之气。”
现代医学研究:荷叶含有莲碱、原荷叶碱和荷叶碱等多种生物碱及维生素C、多糖。有良好的降血脂、降胆固醇和减肥的作用。
本原料生于山野,采于自然,无任何化学添加剂。纯天然、无污染、绿色生态,堪称天然的绿色疗法。黄精三叶茶彻底避免了西药毒副作用对人体的危害。是保健养生,四季馈赠亲友之健康佳品。
本发明与现有技术相比具有以下有益效果:本发明含有多种活性物质和30余种微量元素。具有益气养阴、活血化瘀、润肤养颜、减肥降脂、乌须黑发、清除血内瘀毒,延缓机体衰老,对预防和治疗各类癌症均有一定疗效。对高血压、高血脂、高血糖、心脑血管病、月经不调、乳腺增生、更年期综合症、蝴蝶斑、老年斑、日晒斑、褐色斑、黑眼圈、眼带、白发等均有非常明显的效果。它是一种养颜、保健、延缓衰老的饮用佳品。
具体实施方式
实施例1
一种黄精三叶茶,其是由以下重量配比的原料配制而成:黄精30份,桑叶30份,柿叶19份,荷叶14份。
实施例2
一种黄精三叶茶,它是由以下重量配比的原料配制而成:黄精32.5份,桑叶33份,柿叶22.5份,荷叶17.5份。
实施例3
一种黄精三叶茶,其是由以下重量配比的原料配制而成:黄精35份,桑叶36份,柿叶26份,荷叶21份。
Claims (2)
1.一种黄精三叶茶,其特征在于:其是由以下重量配比的原料配制而成:黄精30—35份,桑叶30—36份,柿叶19—26份,荷叶14—21份。
2.如权利要求1所述的一种黄精三叶茶,其特征在于:其是由以下重量配比的原料配制而成:黄精32.5份,桑叶33份,柿叶22.5份,荷叶17.5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210257398 CN102742705B (zh) | 2012-07-25 | 2012-07-25 | 黄精三叶茶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210257398 CN102742705B (zh) | 2012-07-25 | 2012-07-25 | 黄精三叶茶 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102742705A true CN102742705A (zh) | 2012-10-24 |
CN102742705B CN102742705B (zh) | 2013-10-30 |
Family
ID=47023480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210257398 Expired - Fee Related CN102742705B (zh) | 2012-07-25 | 2012-07-25 | 黄精三叶茶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102742705B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103229872A (zh) * | 2013-05-10 | 2013-08-07 | 北京绿源求证科技发展有限责任公司 | 一种延缓衰老的食品养生茶冲剂 |
CN104095234A (zh) * | 2014-07-04 | 2014-10-15 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN106260341A (zh) * | 2016-08-16 | 2017-01-04 | 湖南大湘西魔芋有限公司 | 一种黄精茶的生产方法及其产品 |
CN107183268A (zh) * | 2017-06-05 | 2017-09-22 | 安徽精天食品有限公司 | 一种荷叶黄精茶及其制备方法 |
CN107594253A (zh) * | 2017-08-29 | 2018-01-19 | 江西也葛生物科技有限公司 | 一种可预防高血糖的葛根饮料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1159288A (zh) * | 1996-03-07 | 1997-09-17 | 张士舜 | 一种凉茶的生产方法 |
CN1726992A (zh) * | 2005-06-24 | 2006-02-01 | 焦家良 | 一种调节血糖及血脂含量的中药及其制备方法 |
CN101248826A (zh) * | 2008-03-31 | 2008-08-27 | 蔡旻君 | 桑叶茶及其制备方法 |
-
2012
- 2012-07-25 CN CN 201210257398 patent/CN102742705B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1159288A (zh) * | 1996-03-07 | 1997-09-17 | 张士舜 | 一种凉茶的生产方法 |
CN1726992A (zh) * | 2005-06-24 | 2006-02-01 | 焦家良 | 一种调节血糖及血脂含量的中药及其制备方法 |
CN101248826A (zh) * | 2008-03-31 | 2008-08-27 | 蔡旻君 | 桑叶茶及其制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103229872A (zh) * | 2013-05-10 | 2013-08-07 | 北京绿源求证科技发展有限责任公司 | 一种延缓衰老的食品养生茶冲剂 |
CN104095234A (zh) * | 2014-07-04 | 2014-10-15 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN104095234B (zh) * | 2014-07-04 | 2015-10-28 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN106260341A (zh) * | 2016-08-16 | 2017-01-04 | 湖南大湘西魔芋有限公司 | 一种黄精茶的生产方法及其产品 |
CN107183268A (zh) * | 2017-06-05 | 2017-09-22 | 安徽精天食品有限公司 | 一种荷叶黄精茶及其制备方法 |
CN107594253A (zh) * | 2017-08-29 | 2018-01-19 | 江西也葛生物科技有限公司 | 一种可预防高血糖的葛根饮料及其制备方法 |
CN107594253B (zh) * | 2017-08-29 | 2020-10-09 | 江西也葛生物科技有限公司 | 一种可缓解高血糖的葛根饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102742705B (zh) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100472052B1 (ko) | 천연 생약 발효를 이용한 화장품 조성물 | |
CN103054054B (zh) | 一种美容猪皮冻及其制备方法 | |
CN104434618B (zh) | 兼具美白、祛斑印功效的九草绿霜及其制备方法 | |
CN102178237B (zh) | 苦水玫瑰油软胶囊 | |
CN107536774B (zh) | 一种中药黑发润发剂及其制备方法 | |
CN102742705B (zh) | 黄精三叶茶 | |
CN104862190A (zh) | 一种红枣枸杞保健酒 | |
CN105288597B (zh) | 一种治疗皮肤色素沉着的药物 | |
CN103584023A (zh) | 一种抗疲劳的藕粉及其制备方法 | |
CN107998365A (zh) | 一种调理皮肤、身体亚健康的中药及其制备方法 | |
CN102204613A (zh) | 一种稳压、活血中药养生槐茶 | |
CN105875929A (zh) | 一种牛大力袋泡茶及其制备方法 | |
CN105104626A (zh) | 甘露茯茶组合物及其制备方法和用途 | |
CN102318709A (zh) | 虫草五花茶 | |
CN108815015A (zh) | 一种眼膜及其生产工艺 | |
CN107047877A (zh) | 一种复方桑叶茶及其制备方法 | |
CN106038418A (zh) | 山姜茶麸洗发剂及其制备方法 | |
CN101991037B (zh) | 当归不老莓丸及其制作方法 | |
CN104757180A (zh) | 参麦养生中药茶饮品及制备方法 | |
CN106963904A (zh) | 一种美容养颜祛斑的中药组合物及其制备方法 | |
CN108815082A (zh) | 一种面膜及其生产工艺 | |
CN108403603A (zh) | 一种樱桃山柰美容祛斑天然中药面膜膏及其制备方法 | |
CN103156012A (zh) | 保健茶饮 | |
CN107692021A (zh) | 一种美容养颜银耳红枣糕及其制备方法 | |
CN1631217A (zh) | 刺五加、王浆、花粉、蜜浓缩液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 |
|
CF01 | Termination of patent right due to non-payment of annual fee |